Pursuant to section 106(1) of the Medicines Act 1981,
I, Barbara Phillips, Acting Deputy Director-General, Population Health Directorate, Ministry of Health, acting under delegated authority, hereby declare that the medicines listed in Schedule 3 to this notice are classified as pharmacy-only medicines.
This notice shall come into force on 1 May 2011.
Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.
Unless specific reference is made otherwise, every reference applies also to medicines that are:
(a) preparations and admixtures containing any proportion of any substance listed in the notice.
(b) salts and esters of any substance listed in the notice.
(c) preparations or extracts of biological materials listed in the notice.
(d) salts or oxides of elements listed in the notice.
Unless specific reference is made otherwise, every reference to a medicine applies:
(i) if the medicine is in an injection or eye preparation, to any concentration of that medicine; and
(ii) if the medicine is not in an injection or eye preparation, only if the concentration of the medicine is greater than 10 milligrams per litre or per kilogram.
Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using
the free acid, base, alcohol or element unless specifically stated otherwise.
Schedule 3
Pharmacy-only Medicines
Dextromethorphan; in liquid form containing more than 0.25% or in solid dose form containing more
than 15 milligrams per dose form when in packs containing not more than 600 milligrams and with a recommended daily dose of not more than 120 milligrams; in medicines for the treatment of the symptoms of cough and cold in children aged 6-12 years
Phenylephrine; for nasal use in medicines containing more than 1%; for ophthalmic use in medicines containing
5% or less and more than 1%; for oral use in medicines containing more than 50 milligrams per recommended daily dose or in packs containing more than 250 milligrams of phenylephrine per pack; in medicines
for the treatment of the symptoms of cough and cold in children aged 6-12 years
Medicines for General Sale
Please note that the following medicines are now available for general sale.
Dextromethorphan; in liquid form containing 0.25% or less or in solid dose form containing 15 milligrams or
less per dose form when in packs containing not
more than 600 milligrams and with a recommended
daily dose of not more than 120 milligrams; except in medicines for the treatment of the symptoms of cough and cold in children aged 6-12 years
Phenylephrine; for nasal or ophthalmic use in medicines containing 1% or less; for oral use in medicines containing 50 milligrams or less per recommended daily dose
and in packs containing 250 milligrams or less of phenylephrine per pack; except in medicines for the treatment of the symptoms of cough and cold in children aged 6-12 years
Dated this 14th day of January 2011.
BARBARA PHILLIPS, Acting Deputy Director-General, Population Health Directorate, Ministry of Health.